UNSPSC 51102834: Chloroxylenol/isopropyl myristate/undecylenic acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102834 Chloroxylenol/isopropyl myristate/undecylenic acid is a Commodity code that nominally specifies a topical antimicrobial compound, but the recent opportunities tagged to this code show little alignment with that specification. The two posted solicitations—one from the Illinois Department of Public Health for antibiotic tablets and one from Seminole County, Florida for naloxone and drug deactivation systems—bear no relationship to the chemical formulation named in the code. State and local procurement databases sometimes tag opportunities with codes that do not match actual scope, and this code appears to exemplify that mismatch. The work actually being solicited under this code tag does not reflect the product category the UNSPSC number describes.

Recent activity is minimal and geographically scattered. The Illinois Department of Public Health awarded a piggyback contract to Chartwell Rx LLC on August 28, 2026 for pharmaceutical tablets through the MMCAP Infuse cooperative purchasing vehicle, with a total contract value of $2,999,999.11 over the life of the award including renewal options. Seminole County, Florida released an IFB on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, with a response deadline of July 26, 2023 (note: date discrepancy in source record). Neither opportunity reflects the code's nominal pharmaceutical ingredient scope. Firms evaluating this code should confirm actual state and local procurement intent through direct agency contact rather than rely on the code tag alone.